Rebecca Stark
Rebecca joined Drug Discovery News as an Intern in 2023. She is a PhD candidate at University of Southern California where she studies molecular mechanisms of synaptic plasticity in fruit flies. As an intern, she writes about brain function and health from early development to advanced age. When not in the lab or writing, she can be found hiking in the Los Angeles mountains with her dog.
Articles by Rebecca Stark
| 5 min read
Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.
| 5 min read
By masking ketamine from placebo for the first time, researchers reveal the importance of accounting for expectancy in trials testing psychoactive drugs.
| 4 min read
Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.
| 4 min read
Researchers identified schizophrenia risk genes that mediate placental, rather than brain, function, revealing new insight into the disease’s developmental origins.
Page 1 of 1 - 4 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
